Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. - Wikidata - wikimedia - TriplyDB

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

http://www.wikidata.org/entity/Q34786887

about

Glycolipid transfer protein interaction with bilayer vesicles: modulation by changing lipid composition.Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model.How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?Cell-associated transmission of HIV type 1 and other lentiviruses in small-animal models Lipids and membrane microdomains in HIV-1 replication A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice Oral epithelial cells and their interactions with HIV-1.Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy.Targeting Trojan Horse leukocytes for HIV prevention.Novel approaches to inhibiting HIV-1 replication.Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).Nanoparticle-based drug delivery to the vagina: a review.The Role of Lipids in Retrovirus Replication.Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape.Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.Non-specific microbicide product development: then and now Monoclonal and Single Domain Antibodies Targeting β-Integrin Subunits Block Sexual Transmission of HIV-1 in In Vitro and In Vivo Model Systems HIV-1 vaginal transmission: cell-free or cell-associated virus?Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.RNA interference for the treatment of papillomavirus disease.M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding.Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges.Setting the stage: host invasion by HIV.Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.Novel humanized murine models for HIV research.Vaginal concentrations of lactic acid potently inactivate HIV Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection.Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.HIV infection of the genital mucosa in women.The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity.

P2860

Q24538790-E15E1119-CD0E-4FF0-A501-ECFB93CE68A1 Q24815101-1E2E6808-48C2-4C00-9770-FDEE22145668 Q25257230-2449FFB8-A558-4D66-86A0-0E9EC8DE0708 Q26824485-1CB13A78-02B9-4B3A-BA11-1F7F0F8D5A7D Q27489393-6A21322C-E0F9-45D4-88AF-A8D19E5D58EF Q28478394-3B1264D1-27D3-42B6-A4A3-C75981AAF0CB Q30384510-FB556692-49B6-4F88-9AF5-BE2C61138EF8 Q33405725-3BEE40AA-6799-4C65-AC9D-4BFE1C5E913E Q33518390-4BFF69B4-A31D-4752-9915-B4F5B459C8FB Q33624690-EC4DD7F5-8509-447A-9D98-250A6BB85162 Q33654841-AF6CD2E3-D1F3-482F-9292-D66D5B18184B Q33784852-7A1C2E44-846C-4ADD-8C95-7F700E9BF164 Q33967491-91B78BC6-7BF7-43AC-B983-C666D8689217 Q34079533-0FF5D584-7B96-4F54-9A84-088EF5C46FC5 Q34080779-06937B48-D23E-4D68-A59D-3A0B435E74DC Q34150951-C960BD13-4B49-41A9-8E00-A046183383CA Q34548621-1D6E636C-60C6-4105-A094-A6B9C3C47621 Q34768558-4ED3BCAD-EDFA-45EA-8B93-CAC49320AE2A Q34975218-0B2FCAA5-926F-4AC2-95C2-218948744F19 Q35000021-F3BE4891-E28F-4002-AC5B-54B9E31B03F3 Q35005659-7652C1DB-46DC-4F86-89C4-27F4DE2FAF86 Q35042478-DD088613-2FBA-415F-9019-7709B7797773 Q35345283-DF515F79-CB64-4552-ADF1-85E11D99A669 Q35591504-4D9B8383-FE44-4B43-A33F-0214A10C5A8C Q35897398-F9F9BFC8-FC61-489F-8486-5B45D564B076 Q36318116-52B780F5-3D27-4047-9BAE-E309E769229E Q36370878-9A14DB9A-4A3F-4E2F-B02F-DF975D29CFC8 Q36540664-3771E964-68C0-4C2B-A533-16C954A2D528 Q36608485-CDD3506E-8EEF-4AAB-8BC7-45A529D928CF Q36748033-EFEFE22E-8AD6-4BF7-A348-AC56E6CD8EF9 Q36983857-FE33658A-B050-4F72-9983-72FB6F038707 Q37036786-5B446580-EAF5-4938-AA4E-41DFD8AFBAE0 Q37084504-E77A9A1A-ADAD-4E66-AD70-ABA85CAF446B Q37095477-822A6064-8F3E-4D63-8A99-499D317BC77C Q37145333-2D4D5327-79E6-41AD-8E0D-4B2A80F00BC7 Q37258271-F20FB80E-CC2B-4B9C-A9B9-3DE54507ABC5 Q37280240-E22B590C-F286-4D15-81F4-E65F81433DF6 Q37336708-07CD8638-40A4-4DD3-9764-E314E94C862F Q37370910-9EB25A99-8C1A-4477-8D20-446A2E9045C3 Q37511571-128F28DB-8725-48AF-B05E-84616F5A550E

P2860

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

http://www.wikidata.org/entity/Q34786887

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@ast

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@en

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@nl

type

label

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@ast

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@en

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@nl

prefLabel

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@ast

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@en

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@nl

P1433

Q34786887-C1691B84-8E87-4AB4-8264-2E53957B82BF

P1476

Q34786887-EEB8A59B-C3B2-4D24-BCB7-338F30CBA684

P2093

Q34786887-1175FEBF-20A6-4999-999E-8E40E0EBBF94

Q34786887-3F5B0E83-652F-4605-A0BC-0769CFB7AD2C

Q34786887-4BE17801-F9BE-4D08-95B7-C5AC80E72027

Q34786887-4C6CDC28-7A36-45CF-80B4-8E1EBDDB375B

Q34786887-9B4FA4C8-73EA-4094-9560-CE278C4A0DAA

Q34786887-A00C0787-8C0A-47E3-A5A4-7EDE36E9E50E

Q34786887-B189B41A-E4CC-4BD7-B89E-02648039034F

Q34786887-C4CF2A20-90F2-4A64-9AF6-949C3C6C17B8

Q34786887-D8AD052F-DCE5-457D-9205-2C4446D7CA9E

Q34786887-DD445AA7-4F34-4994-BA8C-64113C0F6DCB

P2860

Q34786887-059C4116-331F-49C6-80E7-479BB3AC89FE

Q34786887-05D240DE-DDE8-4FC8-8306-0924B9D63680

Q34786887-09BF2333-03BB-493E-BAE3-A6A68693BD56

Q34786887-0D79A0C3-3A95-452C-8DD3-56D899E9CA1E

Q34786887-250FFB1F-BF09-425B-85F9-AA2B11580AFF

Q34786887-2D5B3A7E-A5D6-4D66-924F-B33863B0813B

Q34786887-2F31203F-5E62-42C7-AF14-167A4E36BECB

Q34786887-3EA5A057-3D46-42BB-814E-BE5C2630DDF5

Q34786887-46392264-DC25-41A9-95D1-B91D5E9D57A2

Q34786887-533AF07C-9414-45C7-8B35-1DBBA759534A

P304

Q34786887-35FE4108-A4A8-4ECE-A5E4-BDF31C683A24

P31

Q34786887-90071B40-B0C3-44B5-9D0A-1A651C82D58D

P356

Q34786887-AAC782DF-CB22-4DAD-A45B-FBF2CC0FA763

P407

Q34786887-3022FBF5-097C-4102-ACF8-CE9FA759BE89

P433

Q34786887-F8067582-87BE-4EA9-94BA-E45E2CB529A1

P478

Q34786887-652164C3-95C5-4FA8-BE2B-81AB898C4A71

P577

Q34786887-0747C4B0-CA77-4933-B75F-D499B1EAC377

P698

Q34786887-A826D0E2-B606-422D-B22A-169849446BA6

P921

Q34786887-530D6E94-8F4D-4CC9-A6D0-FB197C02E947

P932

Q34786887-8BEE39A6-8A31-4251-B21A-9A85240939A1

P356

P1433

Journal of Clinical Investigation

P1476

Vaginal transmission of cell-a ...... cal, membrane-modifying agent.

@en

P2093

James E K Hildreth

http://www.w3.org/2001/XMLSchema#string

Karim Mehrazar

http://www.w3.org/2001/XMLSchema#string

Kevin J Whaley

http://www.w3.org/2001/XMLSchema#string

Kristen V Khanna

http://www.w3.org/2001/XMLSchema#string

Larry Zeitlin

http://www.w3.org/2001/XMLSchema#string

Leonard Shultz

http://www.w3.org/2001/XMLSchema#string

Richard A Cone

http://www.w3.org/2001/XMLSchema#string

Richard B Markham

http://www.w3.org/2001/XMLSchema#string

Thomas R Moench

http://www.w3.org/2001/XMLSchema#string

Timothy E Hoen

http://www.w3.org/2001/XMLSchema#string

P2860

A severe combined immunodeficiency mutation in the mouse

Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

The effect of route of immunization on mucosal immunity and protection.

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Membrane raft microdomains mediate front-rear polarity in migrating cells.

Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.

Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.

T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV.

P304

205-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0213236

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11805132

http://www.w3.org/2001/XMLSchema#string

P921

HIV transmission

P932

150835

http://www.w3.org/2001/XMLSchema#string